BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 4546895)

  • 1. Quinazoline antifolates as inhibitors of growth, dihydrofolate reductase, and thymidylate synthetase of mouse neuroblastoma cells in culture.
    Carlin SC; Rosenberg RN; VandeVenter L; Friedkin M
    Mol Pharmacol; 1974 Mar; 10(2):194-203. PubMed ID: 4546895
    [No Abstract]   [Full Text] [Related]  

  • 2. Elevation of dihydrofolate reductase, thymidylate synthetase, and thymidine kinase in cultured mammalian cells after exposure to folate antagonists.
    Chello PL; McQueen CA; DeAngelis LM; Bertino JR
    Cancer Res; 1976 Jul; 36(7 PT 1):2442-9. PubMed ID: 1277151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental chemotherapy of neuroblastoma. II. Increased thymidylate synthetase activity in a 5-fluorodeoxyuridine-resistant variant of mouse neuroblastoma.
    Baskin F; Carlin SC; Kraus P; Friedkin M; Rosenberg RN
    Mol Pharmacol; 1975 Jan; 11(1):105-17. PubMed ID: 123312
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of thymidylate synthetase by the new quinazoline antifolate, CB 3717; enzyme purification and kinetics.
    Jackman AL; Calvert AH; Hart LI; Harrap KR
    Adv Exp Med Biol; 1984; 165 Pt B():375-8. PubMed ID: 6720434
    [No Abstract]   [Full Text] [Related]  

  • 5. Modulation of both endogenous folates and thymidine enhance the therapeutic efficacy of thymidylate synthase inhibitors.
    van der Wilt CL; Backus HH; Smid K; Comijn L; Veerman G; Wouters D; Voorn DA; Priest DG; Bunni MA; Mitchell F; Jackman AL; Jansen G; Peters GJ
    Cancer Res; 2001 May; 61(9):3675-81. PubMed ID: 11325838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical effects of a quinazoline inhibitor of thymidylate synthetase, N-(4-(N-(( 2-amino-4-hydroxy-6-quinazolinyl)methyl)prop-2-ynylamino) benzoyl)-L-glutamic acid (CB3717), on human lymphoblastoid cells.
    Jackson RC; Jackman AL; Calvert AH
    Biochem Pharmacol; 1983 Dec; 32(24):3783-90. PubMed ID: 6661252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of direct suppression of thymidylate synthase at the 5,10-methylenetetrahydrofolate binding site on the interconversion of tetrahydrofolate cofactors to dihydrofolate by antifolates. Influence of degree of dihydrofolate reductase inhibition.
    Seither RL; Trent DF; Mikulecky DC; Rape TJ; Goldman ID
    J Biol Chem; 1991 Mar; 266(7):4112-8. PubMed ID: 1825652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical and antitumor effects of 5,8-dideazaisopteroylglutamate, a unique quinazoline inhibitor of thymidylate synthase.
    Fernandes DJ; Bertino JR; Hynes JB
    Cancer Res; 1983 Mar; 43(3):1117-23. PubMed ID: 6825083
    [No Abstract]   [Full Text] [Related]  

  • 9. Quinazoline antifolates thymidylate synthase inhibitors: lipophilic analogues with modification to the C2-methyl substituent.
    Hennequin LF; Boyle FT; Wardleworth JM; Marsham PR; Kimbell R; Jackman AL
    J Med Chem; 1996 Feb; 39(3):695-704. PubMed ID: 8576912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3D-QSAR studies on quinazoline antifolate thymidylate synthase inhibitors by CoMFA and CoMSIA models.
    Srivastava V; Gupta SP; Siddiqi MI; Mishra BN
    Eur J Med Chem; 2010 Apr; 45(4):1560-71. PubMed ID: 20153089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quinazoline antifolates inhibiting thymidylate synthase: computer modelling of the N10 substituent.
    Jones TR; Betteridge RF; Neidle S; Jackman AL; Calvert AH
    Anticancer Drug Des; 1989 Mar; 3(4):243-8. PubMed ID: 2930626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carrier- and receptor-mediated transport of folate antagonists targeting folate-dependent enzymes: correlates of molecular-structure and biological activity.
    Westerhof GR; Schornagel JH; Kathmann I; Jackman AL; Rosowsky A; Forsch RA; Hynes JB; Boyle FT; Peters GJ; Pinedo HM
    Mol Pharmacol; 1995 Sep; 48(3):459-71. PubMed ID: 7565626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A potent antitumour quinazoline inhibitor of thymidylate synthetase: synthesis, biological properties and therapeutic results in mice.
    Jones TR; Calvert AH; Jackman AL; Brown SJ; Jones M; Harrap KR
    Eur J Cancer (1965); 1981 Jan; 17(1):11-9. PubMed ID: 7262141
    [No Abstract]   [Full Text] [Related]  

  • 14. Structure-based design of lipophilic quinazoline inhibitors of thymidylate synthase.
    Jones TR; Varney MD; Webber SE; Lewis KK; Marzoni GP; Palmer CL; Kathardekar V; Welsh KM; Webber S; Matthews DA; Appelt K; Smith WW; Janson CA; Villafranca JE; Bacquet RJ; Howland EF; Booth CL; Herrmann SM; Ward RW; White J; Moomaw EW; Bartlett CA; Morse CA
    J Med Chem; 1996 Feb; 39(4):904-17. PubMed ID: 8632414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multivariate analysis and quantitative structure-activity relationships. Inhibition of dihydrofolate reductase and thymidylate synthetase by quinazolines.
    Chen BK; Horváth C; Bertino JR
    J Med Chem; 1979 May; 22(5):483-91. PubMed ID: 110930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of thymidylate synthetase of the human lymphocytes.
    Haurani FI
    Cancer Biochem Biophys; 1979; 4(2):75-7. PubMed ID: 317899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of thymidylate synthetase and dihydrofolate reductase by naturally occurring oligoglutamate derivatives of folic acid.
    Friedkin M; Plante LT; Crawford EJ; Crumm M
    J Biol Chem; 1975 Jul; 250(14):5614-21. PubMed ID: 1095583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quinazoline antifolate thymidylate synthase inhibitors: gamma-linked L-D, D-D, and D-L dipeptide analogues of 2-desamino-2-methyl-N10-propargyl-5,8-dideazafolic acid (ICI 198583).
    Bavetsias V; Jackman AL; Kimbell R; Gibson W; Boyle FT; Bisset GM
    J Med Chem; 1996 Jan; 39(1):73-85. PubMed ID: 8568829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of anti-metabolite effects. Effects of thymidine on the efficacy of the quinazoline-based thymidylate synthetase inhibitor, CB3717.
    Jackman AL; Taylor GA; Calvert AH; Harrap KR
    Biochem Pharmacol; 1984 Oct; 33(20):3269-75. PubMed ID: 6487375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quinazoline thymidylate synthase inhibitors: methods for assessing the contribution of polyglutamation to their in vitro activity.
    Jackman AL; Kimbell R; Brown M; Brunton L; Boyle FT
    Anticancer Drug Des; 1995 Oct; 10(7):555-72. PubMed ID: 7495479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.